The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.